• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Editorial Staff
    • Publication Ethics
    • Indexing and Abstracting
    • Related Links
    • FAQ
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Reviewers
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
Asian Pacific Journal of Cancer Prevention
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 20 (2019)
Volume Volume 19 (2018)
Volume Volume 18 (2017)
Volume Volume 17 (2016)
Volume Volume 16 (2015)
Volume Volume 15 (2014)
Issue Issue 24
Issue Issue 23
Issue Issue 22
Issue Issue 21
Issue Issue 20
Issue Issue 16
Issue Issue 15
Issue Issue 14
Issue Issue 19
Issue Issue 18
Issue Issue 17
Issue Issue 13
Issue Issue 12
Issue Issue 11
Issue Issue 10
Issue Issue 9
Issue Issue 8
Issue Issue 7
Issue Issue 6
Issue Issue 5
Issue Issue 4
Issue Issue 3
Issue Issue 2
Issue Issue 1
Volume Volume 14 (2013)
Volume Volume 13 (2012)
Volume Volume 12 (2011)
Volume Volume 11 (2010)
Volume Volume 10 (2009)
Volume Volume 9 (2008)
Volume Volume 8 (2007)
Volume Volume 7 (2006)
Volume Volume 6 (2005)
Volume Volume 5 (2004)
Volume Volume 4 (2003)
Volume Volume 3 (2002)
Volume Volume 2 (2001)
Volume Volume 1 (2000)
(2014). Outcome of Surgery and Post-Operative Radiotherapy for Major Salivary Gland Carcinoma: Ten Year Experience from a Single Institute. Asian Pacific Journal of Cancer Prevention, 15(19), 8259-8263.
. "Outcome of Surgery and Post-Operative Radiotherapy for Major Salivary Gland Carcinoma: Ten Year Experience from a Single Institute". Asian Pacific Journal of Cancer Prevention, 15, 19, 2014, 8259-8263.
(2014). 'Outcome of Surgery and Post-Operative Radiotherapy for Major Salivary Gland Carcinoma: Ten Year Experience from a Single Institute', Asian Pacific Journal of Cancer Prevention, 15(19), pp. 8259-8263.
Outcome of Surgery and Post-Operative Radiotherapy for Major Salivary Gland Carcinoma: Ten Year Experience from a Single Institute. Asian Pacific Journal of Cancer Prevention, 2014; 15(19): 8259-8263.

Outcome of Surgery and Post-Operative Radiotherapy for Major Salivary Gland Carcinoma: Ten Year Experience from a Single Institute

Article 39, Volume 15, Issue 19, December 2014, Page 8259-8263  XML PDF (427.59 K)
Abstract
Aims: To determine the clinical characteristics, pathological features, local and distant failure patterns inpatients with carcinoma of major salivary glands treated with surgery and postoperative radiotherapy (PORT).Materials and
Methods: We retrospectively reviewed 106 cases of major salivary gland tumor seen at our centre(1998-2008). Sixty five cases of major salivary gland carcinoma were selected for analysis (exclusions: benign,palliative, non-carcinomas). The patient population treated by surgery and PORT was divided into two groups:1) Patients who underwent surgery and immediate PORT (Primary PORT); 2) Patients with recurrent carcinomawho underwent at least two surgeries and received PORT in the immediate post-operative period of the lastperformed surgery (Recurrent PORT). Recurrence free survival (RFS) was assessed using the Kaplan-Meiermethod.
Results: Median age was 35 years with a male: female ratio of 1.3:1. The majority of cancers were locatedin the parotid gland (86.2%) and the most common histology was mucoepidermoid carcinoma (43%). Thirtynine cases (60%) were primary while 26 (40%) were recurrent. Optimal surgery was performed in 59/65 patients(90.8%). 43 patients (66.2%) underwent neck dissection, of which 14 (32.5%) had nodal metastasis. Overall, 61(93.8%) patients complied with the prescribed radiotherapy. Median dose of PORT was 60 Gy. Median follow-upwas 13.1 months (range 2-70). Relapse free survival was 50.4% at 60 months. Some 12 cases (18.5%) recurredwith a median time to recurrence of 16.9 months.
Conclusions: Surgery and PORT is an effective treatmentfor major salivary gland carcinoma with over 90% compliance and <20% recurrence. Early treatment withpostoperative radiotherapy may increase the survival rate in major salivary gland carcinoma patients.
Keywords
Major salivary gland; Carcinoma; radiotherapy; Surgery; outcome
Statistics
Article View: 339
PDF Download: 440
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

 



 

Journal Management System. Designed by sinaweb.